Differential calcium handling in two canine models of right ventricular pressure overload

Journal of Surgical Research

Volumn 178, Issue 2, 2012, Pages 554-562

  Moon, Marc R ^a   Aziz, Abdulhameed ^a   Lee, Anson M ^a   Moon, Cynthia J ^a   Okada, Shoichi ^a   Kanter, Evelyn M ^a   Yamada, Kathryn A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Calcium handling proteins; Chronic pulmonary hypertension; Dehydromonocrotaline; Pulmonary banding; Right atrium; Right ventricular hypertrophy

Indexed keywords

CALCIUM HANDLING PROTEIN; MONOCROTALINE PYRROLE; PHOSPHOLAMBAN; PROTEIN; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SERINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EXPERIMENTAL DOG; HEART RIGHT VENTRICLE HYPERTROPHY; HEART RIGHT VENTRICLE OVERLOAD; HEART RIGHT VENTRICLE PRESSURE; LUNG ARTERY BANDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PULMONARY HYPERTENSION; STERNOTOMY;

ANIMALS; CALCIUM; CALCIUM-BINDING PROTEINS; DISEASE MODELS, ANIMAL; DOGS; HEART VENTRICLES; MONOCROTALINE; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; VENTRICULAR DYSFUNCTION, RIGHT; VENTRICULAR PRESSURE;

EID: 84869088602     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2012.04.066     Document Type: Article

References (50)

1. 2+ release channels in rat cardiac hypertrophy induced by aortic stenosis Circulation 98 1998 2477
2. S. Huke, L.H. Liu, and A.W.T. Biniakiewicz Altered force-frequency response in non-failing hearts with decreased SERCA pump-level Cardiovasc Res 59 2003 668
3. 2+ transport proteins in the right atrium in rabbits Am J Physiol Heart Circ Physiol 296 2009 H1933
4. M. Sano, T. Minamino, and H. Toko p53-induced inhibition of Hig-1 causes cardiac dysfunction during pressure overload Nature 446 2007 444
5. M. Shanmugam, S. Gao, and C. Hong Ablation of phospholamban and sarcolipin results in cardiac hypertrophy and decreased cardiac contractility Cardiovasc Res 89 2011 353
6. P. Boknik, C. Unkel, and U. Kirchhefer Regional expression of phospholamban in the human heart Cardiovasc Res 43 1999 67
7. 2+-ATPase activity in guinea pig ventricles J Biol Chem 258 1983 464
8. I. Luss, P. Boknik, and L.R. Jones Expression of cardiac calcium regulatory proteins in atrium v ventricle in different species J Mol Cell Cardiol 31 1999 1299
9. T. Weber, J. Neumann, and A. Meibner Reduced serine-16 and threonine-17 phospholamban phosphorylation in stunning of conscious dogs Basic Res Cardiol 101 2006 253
10. T. Dieterle, M. Meyer, and Y. Gu Gene transfer of a phospholamban- targeted antibody improves calcium handling and cardiac function in heart failure Cardiovasc Res 67 2005 678
11. 2+-ATPase in failing and nonfailing human myocardium Circ Res 75 1994 434
12. 2+ transport and mechanics in compensated pressure-overload hypertrophy and congestive heart failure Circ Res 77 1995 759
13. O.J. Muller, M. Lange, and H. Rattunde Transgenic rat hearts overexpressing SERCA2a show improved contractility under baseline conditions and pressure overload Cardiovasc Res 59 2003 380
14. J.B. Sande, I. Sjaastad, and I.B. Hoen Reduced level of serine(16) phosphorylated phospholamban in the failing rat myocardium: a major contributor to reduced SERCA2 activity Cardiovasc Res 53 2002 382
15. H.J. Bogaard, R. Natarajan, and S. Mizuno Adrenergic receptor blockade reverses right heart remodeling and dysfunction in pulmonary hypertensive rats Am J Respir Crit Care Med 182 2010 652
16. E.J. Molina, D. Gupta, and J. Palma Right ventricular beneficial effects of beta adrenergic receptor kinase inhibitor (βARKct) gene transfer in a rat model of severe pressure overload Biomed Pharmacother 63 2009 331
17. E.J. Molina, D. Gupta, and J. Palma Right ventricular beneficial effects of intracoronary SERCA2a gene transfer in an experimental model of heart failure Folia Biol (Praha) 56 2010 1
18. 2+ ATPase type 2 (SERCA 2) in cardiac sarcoplasmic reticulum from rabbits with heart failure Cardiovasc Res 41 1999 135
19. 2+ cycling contributes to improved contractile performance in SERCA2a- overexpressing transgenic rats Cardiovasc Res 67 2005 636
20. N. Hiranandani, T. Bupha-Intr, and P.M.L. Janssen SERCA overexpression reduces hydroxyl radical injury in murine myocardium Am J Physiol Heart Circ Physiol 291 2006 H3130
21. R. Roncon-Albuquerque, M. Vasconcelos, and A.P. Lourenco Acute changes of biventricular gene expression in volume and right ventricular pressure overload Life Sci 78 2006 2633
22. T. Seyfarth, H.P. Gerbershagen, and C. Giessler The cardiac β-adrenoreceptor-G-protein(s)-adenylyl cyclase system in monocrotaline-treated rats J Mol Cell Cardiol 32 2000 2315
23. H.J. Bogaard, K. Abe, and A.V. Noordegraaf The right ventricle under pressure. Cellular and molecular mechanisms of right-heart failure in pulmonary hypertension Chest 135 2009 794
24. A. Pasipoularides, M. Shu, and A. Shah Right ventricular diastolic function in canine models of pressure overload, volume overload, and ischemia Am J Physiol Heart Circ Physiol 283 2002 H2140
25. K.O. Larsen, I. Sjaastad, and A. Svinndland Alveolar hypoxia induces left ventricular diastolic dysfunction and reduces phosphorylation of phospholamban in mice Am J Physiol Heart Circ Physiol 291 2006 H507
26. E.P. Chen, D.M. Craig, and H.B. Bittner Pharmacological strategies for improving diastolic dysfunction in the setting of chronic pulmonary hypertension Circulation 97 1998 1606
27. E.P. Chen, S.A. Akhter, and H.B. Bittner Molecular and functional mechanisms of right ventricular adaptation in chronic pulmonary hypertension Ann Thorac Surg 67 1999 1053
28. R. Gust, and D.P. Schuster Vascular remodeling in experimentally induced subacute canine pulmonary hypertension Exp Lung Res 27 2001 1
29. C. Lovoulos, S. Tittle, and L. Goldstein Right ventricle-sparing heart transplantation effective against iatrogenic pulmonary hypertension J Heart Lung Transplant 23 2004 236
30. K.R. Stenmark, B. Meyrick, and N. Galie Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure Am J Physiol Lung Cell Mol Physiol 297 2009 L1013
31. J.G. Gomez-Arroyo, L. Farkas, and A.A. Alhussaini The monocrotaline model of pulmonary hypertension in perspective Am J Physiol Lung Cell Mol Physiol 302 2012 L363
32. J.G. Gomez-Arroyo, S.J. Saleem, and S. Mizuno A brief overview of mouse models of pulmonary arterial hypertension: Problems and prospects Am J Physiol Lung Cell Mol Physiol 302 2012 L977
33. J.E. Calvin, R.W. Baer, and S.A. Glantz Pulmonary artery constriction produces a greater RV dynamic afterload than lung microvascular injury in the open chest dog Circ Res 56 1985 40
34. S.L. Gaynor, H.S. Maniar, and J.B. Bloch Right atrial and ventricular adaptation to chronic right ventricular pressure overload Circulation 112 Suppl I 2005 I-212
35. C.M. Hsieh, G.J. Mishkel, and P.F.G. Cardoso Production and reversibility of right ventricular hypertrophy and right heart failure in dogs Ann Thorac Surg 54 1992 104
36. H.S. Maniar, S.M. Prasad, and S.L. Gaynor Impact of pericardial restraint on right atrial mechanics during acute right ventricular pressure load Am J Physiol Heart Circ Physiol 284 2003 H350
37. R.K. Voeller, A. Aziz, and H.S. Maniar Differential modulation of right ventricular strain and right atrial mechanics in mild versus severe pressure overload Am J Physiol Heart Circ Physiol 301 2011 H2362
38. A. Zierer, R.K. Voeller, and S.J. Melby Impact of calcium-channel blockers on right heart function in a controlled model of chronic pulmonary hypertension Eur J Anaesthesiol 26 2009 253
39. A.R. Mattocks, R. Jukes, and J. Brown Simple procedures for preparing putative toxic metabolites of pyrrolizidine alkaloids Toxicon 27 1989 561
40. A. Zierer, S.J. Melby, and R.K. Voeller Interatrial shunt for chronic pulmonary hypertension: Differential impact of low-flow versus high-flow shunting Am J Physiol Heart Circ Physiol 296 2009 H639
41. M.M.R. Amirhamzeh, D.A. Dean, and C. Jia Validation of right and left ventricular conductance and echocardiography for cardiac function studies Ann Thorac Surg 62 1996 1104
42. 2+-binding protein S100A1 in the heart leads to increased in vivo myocardial contractile performance J Biol Chem 278 2003 33809
43. 2+ load mediates impaired contractile reserve in right ventricular pressure overload J Mol Cell Cardiol 43 2007 552
44. R. Rajkumar, K. Konishi, and T.J. Richards Genomewide RNA expression profiling in lung identifies distinct signatures in idiopathic pulmonary arterial hypertension and secondary pulmonary hypertension Am J Physiol Heart Circ Physiol 298 2010 H1235
45. D. Verhaert, W. Mullens, and A. Borowski Right ventricular response to intensive medical therapy in advanced decompensated heart failure Circ Heart Fail 3 2010 340
46. J.I. Drake, H.J. Bogaard, and S. Mizuno Molecular signature of a right heart failure program in chronic severe pulmonary hypertension Am J Respir Cell Mol Biol 45 2011 1239
47. S. Mizuno, H.J. Bogaard, and D. Kraskauskas p53 Gene deficiency promotes hypoxia-induced pulmonary hypertension and vascular remodeling in mice Am J Physiol Lung Cell Mol Physiol 300 2011 L753
48. H. Kogler, O. Harmann, and K. Leineweber Mechanical load-dependent regulation of gene expression in monocrotaline-induced right ventricular hypertrophy in the rat Circ Res 93 2003 230
49. H.J. Bogaard, R. Natarajan, and S.C. Henderson Chronic pulmonary artery pressure elevation is insufficient to explain right heart failure Circulation 120 2009 1951
50. E.D. Michelakis, M.R. Wilkins, and M. Rabinovitch Emerging concepts and translational priorities in pulmonary arterial hypertension Circulation 118 2008 1486